Drawing for HEMADY

USPTO serial 88519605

HEMADY

Reviewed by CopyMark Law Group

Reg. 6017211Status 702Renewal
Filing date
Status date
Registration date
Mar 24, 2020
Examiner
BURCH, JILLIAN RENEE
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with HEMADY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancerACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 28, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 28, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 23, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 29, 2026E815TEAS SECTION 8 & 15 RECEIVED
Mar 24, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 24, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 7, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 15, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 15, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 12, 2019ALIEASSIGNED TO LIE
Nov 5, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 3, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2019DOCKASSIGNED TO EXAMINER
Jul 24, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance